Galderma, the Dermatology Category Leader, Celebrates the Grand Opening of US Headquarters in Dallas

By Rahul Gotadki , 27 December, 2022

Galderma has announced the official opening of its US headquarters in downtown Dallas. Galderma's nearly 300 home office employees were relocated to the Trammell Crow Center at 2001 Ross Avenue. On Friday, December 9, Dallas Mayor Eric Johnson, Galderma Chief Executive Officer Flemming Ørnskov, MD, MPH, representatives from the Downtown Dallas Initiative, and Galderma associates attended the grand opening event.

 

The Trammell Crow Center's cutting-edge office space on the 16th and 17th floors has 50,000 square feet and offers stunning views of downtown and the Dallas Arts District. Its interior is modern and open, intending to encourage collaboration, creativity, productivity, and connections. The new offices include adjustable desks for both standing and sitting, a private nursing room for mothers of newborns, and many lounge areas with soft seating and large meeting spaces for company events and celebrations to promote comfort and well-being.

 

Galderma is the pure-play dermatology category leader, with a unique dermatology legacy and decades of cutting-edge innovation. Galderma provides a synergistic portfolio of premium flagship brands that span the entire spectrum of the rapidly expanding dermatology market. These brands hold the top market positions in their respective product categories and are distinguished by science-based product differentiation and premium positioning. Galderma's portfolio in dermo-cosmetics includes dermatologist-approved Cetaphil moisturizing and cleansing products for sensitive skin, the physician-dispensed Alastin product line, and Differin, the first FDA-approved prescription-strength retinoid acne treatment available without a doctor's prescription. Its injectable aesthetics portfolio contains various hyaluronic fillers, as well as a biostimulator, and a neuromodulator. Galderma Therapeutic Dermatology products include physician-prescribed, FDA-approved acne, and rosacea treatments.

Injectables market value projection

Latest News

Injectables market value projection
Declining Growth Rate Of ESG Funds In The United States

Globally, nations are investing mindfully in sustainable development to achieve clean energy transition goals in the next three decades. Developed countries like the United States are engaged in sustainable investments. However, the ESG (environment…

Read More

Injectables market value projection
Advanced Economies May Suffer Downfall With Less Energy Storage for Future

Globally, the countries are adopting renewables to go greener by 2050. Countries are focusing on utilizing renewables as their energy source. It is to support the clean energy transition by limiting carbon and other harmful gas emissions. However…

Read More

Injectables market value projection
Advanced Economies May Suffer Downfall With Less Energy Storage for Future

Globally, the countries are adopting renewables to go greener by 2050. Countries are focusing on utilizing renewables as their energy source. It is to support the clean energy transition by limiting carbon and other harmful gas emissions. However…

Read More

Injectables market value projection
Summer Travels To Elevate The Oil Demand In 2024

Oil consumption maintains a certain level, although oil prices are elevating at a standard rate in 2024. Organization of the Petroleum Exporting Countries (OPEC) suggests that global oil demand is expected to increase in the summer of 2024.

The…

Read More

Injectables market value projection
Auto Industry Trends: Electric Vehicles Sales May Boom or Crash in 2024

The automotive industry follows different trends since the beginning of 2024. The automotive industry has experienced many issues in the past two years due to the insufficiency of raw materials and disruptions in the supply chain. However, the sector…

Read More

Author Pic
Rahul Gotadki

Assistant Manager